A Combination Therapy Including Anti-PD-1 Immunotherapy in MSS Rectal Cancer With Resectable Distal Metastasis

Clinical trial NCT05359393 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05359393
Sponsor: Fudan University
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Rectal Cancer Liver Metastasis Pulmonary Metastasis Microsatellite Stable Colorectal Carcinoma

Start date: 2022-12-01
Primary completion: 2027-09-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.